摘要
目的 探讨血清中肿瘤标志物 CA19 9 和癌胚抗原(CEA)在胰腺癌诊断中的临床价值。方法 采用Elecsys2010全自动电化学发光免疫分析仪测定32例胰腺癌、32 例良性胰腺病血清中CA19 9、CEA的水平。结果 胰腺癌组 CA19 9 、CEA的测定值分别为:(106.3±79.1) ng/ml、(7.2±0.7)ng/ml,均显著高于良性胰腺病组。结论 CA19 9对胰腺癌的诊断价值高于 CEA,CA19 9与CEA的联合检测对胰腺癌的诊断具有一定的临床应用价值。
Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreas cancer.Methods The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreas cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were (106.3±79.1)ng/ml and (7.2±0.7)ng/ml ,which were significantly higher than those in the latter group.Conculsion The value of CA19-9 in diagnosing of pancreas cancer is higher than that of CEA .But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreas cancer .
出处
《国外医学（临床生物化学与检验学分册）》
2005年第1期6-7,共2页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
